Luo, Ji
Brakel, Alexandra
Krizsan, Andor
Ludwig, Tobias
Mötzing, Marina
Volke, Daniela
Lakowa, Nicole
Grünewald, Thomas http://orcid.org/0000-0002-2955-3085
Lehmann, Claudia
Wolf, Johannes
Borte, Stephan
Milkovska-Stamenova, Sanja
Gabert, Jörg
Fingas, Felix
Scholz, Markus
Hoffmann, Ralf http://orcid.org/0000-0001-9932-5646
Funding for this research was provided by:
European Regional Development Fund (100523073)
Deutsche Forschungsgemeinschaft (INST 268/387-1)
Universität Leipzig
Article History
Received: 1 November 2021
Accepted: 24 February 2022
First Online: 19 March 2022
Declarations
:
: The investigations represent parts of the analyzes in the COVID genetics cohort Leipzig-Chemnitz, which was approved by the Institutional Review Board of Leipzig University (reference numbers 195/20-ek and EK-allg-37/10-1).
: Not applicable.
: MS receives funding from Pfizer Inc. for a project not related to this research. JL, SMS, and FF are employees of Adversis Pharma GmbH. JG is cofounder and CEO of Adversis Pharma GmbH. All other authors declare that they have no competing interests.